Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

External Collaborations

Jörg Huwyler, Pharmazeutisches Institut Universität Basel (Switzerland): “Non-viral delivery of Parvoviral Oncotoxins”

Markus Möhler, Universitätsklinikum Mainz (Deutschland): “Anti-tumor activities of oncolytic Parvoviruses”

Uwe Truyen, Institut für Tierhygiene Universität Leipzig, (Deutschland): “Persisent Infections of porcine parvoviruses in pigs”

Peter Tatterall, Yale University, New Haven (USA): “Parvovirus non-structural protein functioning”

Claytus Davis, Ben Gurion University of the Negev, Beer Sheva (Israel): “PV interaction with the host innate immune and stress responses”

Nathalia Giese, Universitätsklinikum Heidelberg (Deutschland): „Parvoviruses for treatments of PDAC“.

Laurent Daeffler, Institut Pluridisciplinaire Hubert Curien, UMR 7178, CNRS, Strassbourg (France). „Parvovirus-induced innate immune-responses.“

Maria Söderlund-Venermo, University Helsinki (Finland). “Properties of human Prosotparvoviruses”.

 

to top
powered by webEdition CMS